Anti-tachycardia pacing in the VT zone

Summary

• Episode classified in the VT zone
• 1 burst

• A priority when programming an implantable defibrillator is to reduce the number of shocks delivered as much as possible without compromising patient safety; the ideal scenario is to interrupt the tachycardia with the least aggressive and least painful therapy possible; anti-tachycardia pacing is therefore the preferred first-line therapy for organized reentrant tachycardias since it is less painful and reduces battery consumption compared to shocks.
• The basic principle of anti-tachycardia pacing is based on the existence of an excitation window in a reentrant circuit during which rapid pacing can generate a new activation front that collides with the tachycardia circuit and interrupts it; the ventricle must therefore be paced at a higher rate than the tachycardia
• The efficacy of this type of therapy has been demonstrated for a wide range of ventricular tachycardia rates up to 240 beats/minute; anti-tachycardia pacing terminates around 90% of ventricular tachycardias with rates below 200 beats/minute, with a moderate risk of acceleration on the order of 1 to 5%.
• These observations have repositioned the implantable “defibrillator” as a first-line treatment for arrhythmias through rapid pacing, with the possibility of defibrillation as a back-up only.
• One or more ATP sequences can be programmed empirically, without the need for prior electrophysiological testing of efficacy
• This patient presented with numerous episodes of VT effectively treated by anti-tachycardia pacing; rapid and effective treatment by pacing enabled the patient to remain asymptomatic with a preserved quality of life while preserving the battery’s longevity